Effectiveness of Diaphragm Treatment in Reducing Low Back Pain
Launched by UNIVERSITY OF SEVILLE · Oct 4, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether adding a specific stretching technique for the diaphragm can help reduce low back pain in patients who receive standard physiotherapy treatment. The study will compare two groups: one group will receive traditional physiotherapy, including massage and electrotherapy, while the other group will receive the same treatments plus the diaphragm stretching technique. Researchers want to see if this additional technique improves mobility, reduces pain, and enhances quality of life for those with mechanical low back pain.
To participate in this trial, you need to be at least 18 years old and have been diagnosed with subacute or chronic mechanical low back pain by a doctor. It’s important that you also have a dysfunction of the diaphragm, which is a muscle involved in breathing. However, certain conditions, such as previous surgeries or specific medical issues, may exclude you from participating. If you join the study, you will attend ten treatment sessions over two weeks, and your progress will be monitored through various tests to measure pain, movement, and overall health before, during, and after treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient diagnosed with subacute or chronic mechanical low back pain by a specialist doctor and who has attended in "Fisioclinic" physiotherapy clinic.
- • Older than 18 years-old.
- • Indistinct sex.
- • Diaphragm dysfunction.
- Exclusion Criteria:
- • Any surgical intervention on the upper and lower limbs, head, spine, thorax or abdomen at any time in their lives, with a visible anatomy cause on imaging tests.
- • Any pathology of non-mechanical origin, such as inflammatory, infectious, tumorous, neurological, traumatic processes and bone diseases in the lumbar spine.
- • Having received analgesic or anti-inflammatory medical treatment for pain in a period of less than two weeks.
- • Pregnant women, including the breastfeeding period.
- • Patients receiving chemotherapy or radiotherapy.
- • Basic systemic disease of rheumatic origin (for example, arthritis, osteoarthritis, gout and psoriasis).
- • Implanted electronic devices.
- • Drug or alcohol abuse, analgesic or sedative therapy and use of medications that affect the central nervous system (for example, antidepressants, anxiolytics and anticonvulsants).
- • Patients who have previous experience with manual treatment of the diaphragm.
- • Patients with high work activity.
- • Outside the age range for the study.
- • Refusal to participate in the study.
- • Refusal to complete and sign the informed consent.
About University Of Seville
The University of Seville is a prestigious academic institution dedicated to advancing knowledge through innovative research and exceptional education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at enhancing patient care and medical outcomes. Its commitment to rigorous scientific inquiry and ethical standards positions it as a leading sponsor in the field of clinical research, fostering partnerships with healthcare professionals and institutions to drive advancements in medical science and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sevilla, Seville, Spain
Patients applied
Trial Officials
Juan Antonio Díaz-Mancha, PhD
Principal Investigator
University of Seville
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported